| Title |
Six Action Steps to Address Global Disparities in Parkinson Disease
|
|---|---|
| Published in |
JAMA Neurology, September 2022
|
| DOI | 10.1001/jamaneurol.2022.1783 |
| Pubmed ID | |
| Authors |
Nicoline Schiess, Rodrigo Cataldi, Michael S. Okun, Natasha Fothergill-Misbah, E. Ray Dorsey, Bastiaan R. Bloem, Maria Barretto, Roongroj Bhidayasiri, Richard Brown, Lorraine Chishimba, Neerja Chowdhary, Max Coslov, Esther Cubo, Alessandro Di Rocco, Rachel Dolhun, Christopher Dowrick, Victor S. C. Fung, Oscar S. Gershanik, Larry Gifford, Joyce Gordon, Hanan Khalil, Andrea A. Kühn, Sara Lew, Shen-Yang Lim, Maria M. Marano, Jacquie Micallef, Jolynne Mokaya, Emile Moukheiber, Lynda Nwabuobi, Njideka Okubadejo, Pramod Kumar Pal, Hiral Shah, Ali Shalash, Todd Sherer, Bernadette Siddiqui, Ted Thompson, Andreas Ullrich, Richard Walker, Tarun Dua |
| Abstract |
The Global Burden of Disease study conducted between 1990 and 2016, based on a global study of 195 countries and territories, identified Parkinson disease (PD) as the fastest growing neurological disorder when measured using death and disability. Most people affected by PD live in low- and middle-income countries (LMICs) and experience large inequalities in access to neurological care and essential medicines. This Special Communication describes 6 actions steps that are urgently needed to address global disparities in PD. The adoption by the 73rd World Health Assembly (WHA) of resolution 73.10 to develop an intersectoral global action plan on epilepsy and other neurological disorders in consultation with member states was the stimulus to coordinate efforts and leverage momentum to advance the agenda of neurological conditions, such as PD. In April 2021, the Brain Health Unit at the World Health Organization convened a multidisciplinary, sex-balanced, international consultation workshop, which identified 6 workable avenues for action within the domains of disease burden; advocacy and awareness; prevention and risk reduction; diagnosis, treatment, and care; caregiver support; and research. The dramatic increase of PD cases in many world regions and the potential costs of PD-associated treatment will need to be addressed to prevent possible health service strain. Across the board, governments, multilateral agencies, donors, public health organizations, and health care professionals constitute potential stakeholders who are urged to make this a priority. |
X Demographics
The data shown below were collected from the profiles of 57 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 13 | 23% |
| Japan | 3 | 5% |
| Netherlands | 2 | 4% |
| Canada | 2 | 4% |
| United Kingdom | 2 | 4% |
| Luxembourg | 1 | 2% |
| Italy | 1 | 2% |
| Spain | 1 | 2% |
| Malaysia | 1 | 2% |
| Other | 8 | 14% |
| Unknown | 23 | 40% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 38 | 67% |
| Scientists | 14 | 25% |
| Practitioners (doctors, other healthcare professionals) | 4 | 7% |
| Science communicators (journalists, bloggers, editors) | 1 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 70 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 70 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 7 | 10% |
| Student > Ph. D. Student | 6 | 9% |
| Other | 5 | 7% |
| Researcher | 4 | 6% |
| Student > Bachelor | 3 | 4% |
| Other | 10 | 14% |
| Unknown | 35 | 50% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 8 | 11% |
| Neuroscience | 5 | 7% |
| Nursing and Health Professions | 4 | 6% |
| Unspecified | 4 | 6% |
| Sports and Recreations | 2 | 3% |
| Other | 14 | 20% |
| Unknown | 33 | 47% |
Attention Score in Context
This research output has an Altmetric Attention Score of 78. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 September 2022.
All research outputs
#548,385
of 25,392,582 outputs
Outputs from JAMA Neurology
#735
of 5,848 outputs
Outputs of similar age
#13,724
of 432,759 outputs
Outputs of similar age from JAMA Neurology
#22
of 66 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,848 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 44.2. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 432,759 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 66 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.